Pubblicazioni

Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study

2023 - NEUROPSYCHIATRIC DISEASE AND TREATMENT
Giron-Hernandez, Cesar; Han, Joong Hee; Alberio, Roberta; Singh, Arun; García-Portilla, Maria Paz; Pompili, Maurizio; Knight, R Karl; Richarz, Ute; Gopal, Srihari; Antunes, José

Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study

2023 - NEUROPSYCHIATRIC DISEASE AND TREATMENT
Giron-Hernandez, Cesar; Han, Joong Hee; Alberio, Roberta; Singh, Arun; García-Portilla, Maria Paz; Pompili, Maurizio; Knight, R Karl; Richarz, Ute; Gopal, Srihari; Antunes, José

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma